Under the agreement, Allergan will pay $1.9 million to Summit County, Ohio, and $3.1 million to Cuyahoga County, Ohio. The two Ohio counties were chosen to serve as bellwethers in litigation over the opioid epidemic.
Endo International reached an $11 million settlement in August with the two counties.
Allergan and Endo are two of the smaller drugmakers named as defendants in the October trial. Other drugmakers are Purdue Pharma, Teva Pharmaceuticals and Johnson & Johnson.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
